Zou, L.; Che, Z.; Ding, K.; Zhang, C.; Liu, X.; Wang, L.; Li, A.; Zhou, J.
JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway. Antioxidants 2023, 12, 1134.
https://doi.org/10.3390/antiox12051134
AMA Style
Zou L, Che Z, Ding K, Zhang C, Liu X, Wang L, Li A, Zhou J.
JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway. Antioxidants. 2023; 12(5):1134.
https://doi.org/10.3390/antiox12051134
Chicago/Turabian Style
Zou, Lu, Zhen Che, Kun Ding, Chao Zhang, Xia Liu, Luman Wang, Aiping Li, and Jianwei Zhou.
2023. "JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway" Antioxidants 12, no. 5: 1134.
https://doi.org/10.3390/antiox12051134
APA Style
Zou, L., Che, Z., Ding, K., Zhang, C., Liu, X., Wang, L., Li, A., & Zhou, J.
(2023). JAC4 Alleviates Rotenone-Induced Parkinson’s Disease through the Inactivation of the NLRP3 Signal Pathway. Antioxidants, 12(5), 1134.
https://doi.org/10.3390/antiox12051134